Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

  • There is currently no data for SNG

Total Voting Rights

30 Jun 2009 09:56

RNS Number : 7642U
Synairgen plc
30 June 2009
 



30 June 2009

Synairgen plc

("Synairgen" or "the Company")

Total Voting Rights

 

For the purposes of the Financial Services Authority's disclosure and Transparency Rules, the Company's total issued share capital at the date of this notice is 59,745,249. 

The Company's issued share capital consists of 59,745,249 ordinary shares of 1p each, with one voting right per share. There are no shares held in treasury.

The total number of voting rights in the Company is therefore 59,745,249.

The above figure of 59,745,249 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

For more information please contact:

 

Synairgen plc  Tel: + 44 (0) 2380 512 800

Richard Marsden, Managing Director

John Ward, Finance Director

Matrix Corporate Capital  Tel: + 44 (0) 20 3206 7000

Alastair Stratton

Anu Tayal

Threadneedle Communications  Tel: + 44 (0) 20 7653 9850

Graham Herring

Josh Royston

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRCKKKPFBKKAAN
Date   Source Headline
13th Feb 20137:00 amRNSPreliminary Results
5th Dec 20127:00 amRNSTrading Update
30th Oct 20121:44 pmRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSExercise of Options
31st Aug 20127:00 amRNSSynairgen presents proof of concept study
10th Aug 20127:00 amRNSHalf Yearly Report
18th Jul 20127:00 amRNSPlacing
25th Jun 20121:30 pmRNSResult of AGM
22nd May 20127:30 amRNSProfessor Stephen Holgate given prestigious Award
1st May 201212:55 pmRNSHolding(s) in Company
19th Apr 20127:00 amRNSPositive Phase II asthma data
2nd Mar 20127:00 amRNSNotice of Report and Accounts
1st Feb 20127:00 amRNSPreliminary results
30th Jan 20127:00 amRNSNotice of Results
12th Dec 20117:00 amRNSDirector's dealing
8th Dec 20117:00 amRNSEnd of Recruitment in Phase II Asthma Trial
25th Nov 20117:00 amRNSPositive Viral Pneumonia Study Results
10th Nov 201112:40 pmRNSResult of AGM
18th Oct 20111:50 pmRNSNotice of AGM and posting of Annual Reports
22nd Sep 20113:10 pmRNSGrant of options
9th Sep 20117:00 amRNSChange of Adviser
18th Jul 20117:00 amRNSJapanese Patent to be Granted
28th Jun 20117:00 amRNSPhase II asthma study - Interim Review and update
15th Jun 20113:56 pmRNSHolding(s) in Company
13th Jun 201111:54 amRNSResult of General Meeting
27th May 20111:00 pmRNSFundraising
4th May 20117:00 amRNSAntiviral activity against Bird Flu
2nd Feb 201111:31 amRNSHolding(s) in Company
1st Feb 20117:00 amRNSHalf Yearly Report
3rd Nov 20101:35 pmRNSResult of AGM
19th Oct 20107:00 amRNSUS Patent
8th Oct 20109:00 amRNSNotice of AGM and Posting of Annual Report
9th Sep 20107:00 amRNSGrant of Options
29th Jul 20107:00 amRNSFinal Results
27th Jul 20107:00 amRNSNotice of Results
29th Jun 20107:00 amRNSGrant of Options
28th Jun 20107:00 amRNSDirectorate Change
17th May 20107:00 amRNSPositive Influenza Data
6th May 20107:00 amRNSIFN-beta Patent Granted in Europe
1st Apr 20107:00 amRNSPhase II Trials
24th Feb 20103:27 pmRNSHolding(s) in Company
8th Feb 20107:00 amRNSHalf Yearly Report
15th Jan 20107:00 amRNSHolding(s) in Company
12th Nov 20097:00 amRNSSuccessful Outcome of Phase 1 Study
11th Nov 20091:24 pmRNSResult of AGM
9th Nov 20097:00 amRNSactivity of interferon beta against swine flu
26th Oct 20097:00 amRNSNotice of Investor Conference
14th Oct 20092:35 pmRNSNotice of Annual Report and Accounts and AGM
8th Sep 200911:25 amRNSGrant of Options
4th Sep 20097:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.